Orforglipron is a new drug that has proven more effective for weight loss and blood sugar control than injectible semaglutides. Bonus: comes in a daily pill, is cheaper to produce, and the name automatically invokes Rule 34 [Interesting]

The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings

The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings

Canada approves the first generic semaglutide injection for weight loss

Health Canada has approved the first generic semaglutide injection for weight loss.

Canada Approves First Generic Wegovy: What It Means For Weight-Loss Drug Prices

Semaglutide-based drugs, including Novo Nordisk's Ozempic and Wegovy, have seen explosive global demand in recent years for both diabetes management and weight loss, prompting regulators worldwide to...

Health Canada approves weight-loss drug for sleep apnea in patients with obesity

Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity. The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked. That blockage can [] The post Health Canada approves weight-loss drug for sleep apnea in patients with obesity appeared first on CityNews Montreal.

We've already lost 15lb on the new Wegovy weight-loss pill that's cheaper than jabs. Here's everything you need to know about how to get it, side effects - and the trick to turbocharge your weight loss with no extra effort

We've already lost 15lb on the new Wegovy weight-loss pill that's cheaper than jabs. Here's everything you need to know about how to get it, side effects - and the trick to turbocharge your weight loss with no extra effort

FDA Reviews Sandoz Generic Obesity Drug Applications

The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.

Melatonin: Sleep supplement can fix back pain according to Edith Cowan University research

A sleep supplement widely used to treat insomnia could help reduce reliance on some of the most common and potentially harmful pain medications.

Substack 10: Magic Pill and the Satiety Problem Problem

My latest post on Unsettled Science: Johann Hari’s new book, Magic Pill, does a good job on the benefits and risks of taking a drug like Ozempic. It goes off the rails when he gets around to discussing the science of obesity. Consider this the Satiety Problem Problem. Another learning experience (we didn’t need) on...Read More »

Our goal is to bring innovation faster to India: AstraZeneca India-chief

AstraZeneca is focused broadly on oncology (increasingly our largest segment globally and in India); biopharmaceuticals (cardiovascular, renal, respiratory, immunology, and vaccines); and rare diseases.

Weight-loss drugs show possible positive effects in HIV, cancer and other diseases

Drugs such as Ozempic, Mounjaro, and Wegovy are showing effects well beyond weight loss and diabetes treatment, NOS

A patient got the weight loss medication retatrutide before FDA approval. How does that work?

A primer on retatrutide and compassionate use

Canada approves 1st generic semaglutide shot for weight loss

It's the third generic semaglutide product approved by the department, though the first two were authorized for the treatment of Type 2 diabetes in adults.

Abdul Razzaq Siddiq launches 2nd nationwide free “Anti-Snake Bite Serum Program”

Abdul Razzaq Siddiq launches 2nd nationwide free “Anti-Snake Bite Serum Program”

Ascendis Pharma: Behind The Stock Surge

Ascendis Pharma: Behind The Stock Surge

Here’s a look at SEVMIA, the first generic weight-loss injection approved by Health Canada

What to know Health Canada approved the first generic version of the weight-loss drug Wegovy. Here’s what it means for those seeking to lose weight... The post Here’s a look at SEVMIA, the first generic weight-loss injection approved by Health Canada appeared first on NOW Toronto.

Comcast, Viridian Therapeutics jump premarket; Doximity slips

Comcast, Viridian Therapeutics jump premarket; Doximity slips

Oral GLP-1 pill delivers nearly 12 percent weight loss in 36 weeks, study finds

The study found that the drug stimulates insulin secretion, suppresses appetite and increases satisfaction to promote weight loss.

New Study Raises Concerns About GLP-1 Misuse Among People With Eating Disorders

GLP-1 weight-loss drugs like Ozempic and Wegovy seem to be miraculous wonder drugs that can help overweight and obese people shed some pounds, while also producing several other unexpected benefits, like reducing violent impulses and curbing addictions. For all the good they do, a new study published in JAMA Psychiatry raises some concerns about how []

If you've been taking Chlorthalidone for your high blood pressure, this news might not help much more than those pills [Fail]

[link] [1 comments]

AbbVie is buying an eczema and asthma drug developer for nearly $11 billion

The all-cash deal gives AbbVie access to zumilokibart, an experimental drug that could rival Dupixent in treating atopic dermatitis

Curcumin May Help Lower Blood Sugar in Type 2 Diabetes, Study Finds

Curcumin, the active compound found in turmeric, may improve blood sugar control and reduce chronic inflammation in people with type 2 diabetes, according to a scientific review published in Frontiers in Nutrition. Researchers analyzed clinical trials and meta-analyses evaluating several standardized forms of curcumin to assess its potential role in diabetes management. Curcumin Improves Key Diabetes Markers The review found that appropriately formulated and correctly dosed curcumin may lower fasting blood glucose, reduce glycated hemoglobin (HbA1c) levels and improve insulin sensitivity.

This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested

Parabilis Medicines is ambitious, but it has Regeneron on its side already.

WEGOVY THE WONDER DRUG

Lose weight, reduce the risk of CV disease – unless you are taking Wegovy? [A tale of mystery and intrigue unfolds]. A lot of people have asked me about the weight loss drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists) e.g. Wegovy (semaglutide), or Mounjaro (tirzepatide). What do I think of them, are they []

Doctor issues urgent warning for those taking common antidepressants this summer

A doctor has issued an urgent warning to anyone taking common antidepressants this summer, amid serious health concerns for those taking the popular medication

Trouble getting weight loss drugs covered by insurance? Here's what to know

What to do if your insurance denies your obesity drug.

Mike Nesbitt to roll out weight loss medication across Northern Ireland with support from Mounjaro maker Eli Lilly

​​A new £5 million Regional Obesity Management Service (ROMS) is to make weight loss medication available to adults across Northern Ireland.

Anti-drug message echoes in Munajat programme

Anti-drug message echoes in Munajat programme

AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash

AbbVie has agreed to buy Apogee Therapeutics for about 10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.

Eli Lilly’s Unapproved Weight-Loss Drug Is Now Sold at Brooklyn Corner Stores for $95

A CBS News reporter purchased Eli Lilly's experimental weight-loss drug retatrutide at a Brooklyn convenience store for 95 with no prescription as toxicity reports rise and the FDA warns such products are of unknown quality and potentially harmful. The drug is currently in clinical trials and has never received regulatory approval.

Wegovy obesity pill now available at pharmacies

Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.

Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

This Overlooked Plant Compound Could Benefit Blood Sugar, Study Shows

This plant nutrient may offer surprising benefits for blood sugar.

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful.

Over 11,000 bottles of blood pressure medicine recalled across the U.S.

A common blood pressure medicine has been recalled across the country. The Food and Drug Administration has recalled more than 11,000 bottles of a Chlorthalidone.

Discover the Transformative Benefits of HIFU Treatment for Non-Surgical Facelifts

Amongst contemporary beauty treatments, the quest for youthful skin has actually acquired an entire new form with the introduction of hifu treatment. HIFU, or High-Intensity Focused Ultrasound, is a technology that can give people a chance to rejuvenate their skin without having to resort to surgical procedures. What is HIFU Treatment? HIFU is the latest [] The post Discover the Transformative Benefits of HIFU Treatment for Non-Surgical Facelifts appeared first on QuintDaily.

Say Hello to the New Species of Fly Officially Approved to Clean Human Wounds

The FDA has cleared Lucilia cuprina larvae for use in maggot debridement therapy.

Pomegranate’s heart-protecting power: New research reveals how ancient fruit fights disease

(NaturalNews) Punicalagin, a unique antioxidant found almost exclusively in pomegranates, helps restore heart cell function in obese rats Drinking cold-press...